Mr. Arthur is a senior life sciences executive with 25+ years of US and global experience building and leading medical and marketing organizations in product development; launching and managing pharmaceutical and device brands. Prior to accepting the role as Chief Executive Officer Salarius Pharmaceuticals, David was Managing Director Dacon Pharma, LLC. Additionally, David spent 20+ years with Eli Lilly and Boehringer-Ingelheim in executive roles managing product development, business development, US business, global commercialization, European regional marketing and financial planning/analysis.
Mr. Arthur earned a BS in Chemical Engineering from North Carolina State University, a Masters of Business Administration from the Duke University Fuqua School of Business, is a licensed Professional Engineer and Six Sigma Green Belt.
Mr. Arthur earned a BS in Chemical Engineering from North Carolina State University, a Masters of Business Administration from the Duke University Fuqua School of Business, is a licensed Professional Engineer and Six Sigma Green Belt.
Speaking In
[Available On-Demand]
Salarius Pharmaceuticals is a clinical stage oncology biotech developing our lead asset,…